ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,226Medicare Part D Prescriptions Filled, Including Refills

Rank: 32 out of 298

$674K Total Retail Price of All Prescriptions

Rank: 10 out of 298

431 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Dakota
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 431 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

11% of this provider’s 431 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

0% of this provider’s 8,008 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
LEVOTHYROXINE SODIUM 363 302 1 1
SIMVASTATIN 363 322 1 2
OMEPRAZOLE 294 233 3 3
SPIRONOLACTONE 285 241 4 34
FUROSEMIDE 247 221 5 5
PRAVASTATIN SODIUM 235 191 6 31
TRAMADOL HCL 223 179 7 15
LISINOPRIL 207 170 8 4
HYDROCODONE-ACETAMINOPHEN 193 107 S3 9 8
WARFARIN SODIUM 185 185 10 7
CARVEDILOL 185 158 10 23
AMLODIPINE BESYLATE 165 146 12 6
METFORMIN HCL 142 116 13 10
CITALOPRAM HBR 141 129 14 17
FLUTICASONE PROPIONATE 129 93 15 38
POLYETHYLENE GLYCOL 3350 128 116 16 29
METOPROLOL SUCCINATE 126 126 17 12
LOSARTAN POTASSIUM 124 111 18 18
NAMENDA 120 120 19 35
ATORVASTATIN CALCIUM 119 117 20 14
GABAPENTIN 119 71 20 20
JANUVIA 114 103 22 73
BENAZEPRIL HCL 112 109 23 52
RANITIDINE HCL 106 74 24 59
DONEPEZIL HCL 102 102 25 22
POTASSIUM CHLORIDE 96 94 26 11
TAMSULOSIN HCL 94 89 27 24
LISINOPRIL-HYDROCHLOROTHIAZIDE 93 60 28 30
FENOFIBRATE 92 50 29 62
CYMBALTA 85 60 30 67
PREDNISONE 85 71 30 33
METOPROLOL TARTRATE 84 74 32 9
SINGULAIR 82 60 33 136
SPIRIVA 81 59 34 55
BUMETANIDE 77 64 35 71
ZOLPIDEM TARTRATE 74 45 36 25
EXELON 74 74 36 132
DIGOXIN 69 68 38 27
CARBIDOPA-LEVODOPA 65 61 39 49
HYDROCHLOROTHIAZIDE 64 57 40 13
ADVAIR DISKUS 64 30 40 46
TEKTURNA 62 52 42 179
PRAMIPEXOLE DIHYDROCHLORIDE 61 54 43 114
FAMOTIDINE 61 59 43 80
METFORMIN HCL ER 61 55 43 57
ALLOPURINOL 61 57 43 28
LOSARTAN-HYDROCHLOROTHIAZIDE 58 57 47 44
MONTELUKAST SODIUM 56 30 48 198
AVODART 56 55 48 115
TRAZODONE HCL 55 14 50 39
ALENDRONATE SODIUM 54 54 51 21
PEN NEEDLE 52 28 52 190
ZETIA 51 35 53 83
BYSTOLIC 51 36 53 127
QUETIAPINE FUMARATE 50 21 55 68
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 23, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.